MedTrace Logo

The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients

NCT03686605 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2022-07-28

No results posted yet for this study

Summary

Compare Thai versions of the Edmonton Symptom Assessment System (ESAS) and the Hospiral Anxiety and Depression Scale (HADS) with Diagnostic and Statistical Manual (DSM-5), as a screening tool for depression in cancer pain patients

Conditions

  • Screening Tool for Depresion in Cancer Pain Patients

Interventions

OTHER

Thai version of the Edmontom Symptom Assessment System (ESAS)

Screening and diagnostic questionaire for depression

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Suratsawadee Wangnamthip, MD · Lecturer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-24
Primary Completion
2019-12-31
Completion
2020-01-31

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03686605 on ClinicalTrials.gov